首页 | 本学科首页   官方微博 | 高级检索  
     


A primer for personalized medicine
Affiliation:1. Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany;1. Charles Perkins Centre, School of Molecular Bioscience, The University of Sydney, Sydney, NSW 2006, Australia;2. Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia;3. University of Copenhagen, August Krogh Centre, Department of Nutrition, Exercise and Sports, Copenhagen 2100, Denmark;4. Systems Biology Section, Epigenetics & Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA;5. School of Medicine, The University of Sydney, Sydney, NSW 2006, Australia;1. Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Universitetsparken 13, Copenhagen 2100, Denmark;2. Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark;3. Department of Endocrinology, Hvidovre University Hospital, Hvidovre, Denmark;4. Institute of Marine Research, Bergen, Norway;5. Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;6. Clinical Microbiomics, Copenhagen, Denmark;7. Department of Medicine, Laval University, Quebec, QC, Canada;8. Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Munich, Germany;9. The Novo Nordisk Foundation Center for Protein Research, Clinical Proteomics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;10. Institute of Metagenomics, BGI-Shenzhen, Shenzhen, China;1. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;2. Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden;3. Translational Science & Experimental Medicine, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden;4. Karolinska Institutet/AstraZeneca Integrated CardioMetabolic Center (KI/AZ ICMC), Department of Medicine, Novum, Huddinge, Sweden;5. Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark;6. Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden;7. Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden;8. Institute of Computer Science, Polish Academy of Sciences, Warsaw, Poland;9. Washington National Primate Research Center, Seattle, WA, USA;10. Swedish Collegium for Advanced Study, Uppsala, Sweden;11. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark;12. Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany;13. Department of Medicine, University of Gothenburg, Gothenburg, Sweden;1. Department of Molecular & Cellular BioAnalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan;2. PRESTO, Japan Science and Technology Agency (JST), Chiyoda-ku, Tokyo, Japan;3. Laboratory of Clinical and Analytical Chemistry, National Institute of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号